Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy.
van Praag RM, van Weert EC, van Heeswijk RP, Zhou XJ, Sommadossi JP, Jurriaans S, Lange JM, Hoetelmans RM, Prins JM. van Praag RM, et al. Among authors: hoetelmans rm. Antimicrob Agents Chemother. 2002 Mar;46(3):896-9. doi: 10.1128/AAC.46.3.896-899.2002. Antimicrob Agents Chemother. 2002. PMID: 11850283 Free PMC article. Clinical Trial.
The pharmacokinetics of nelfinavir in HIV-1-infected children.
van Heeswijk RP, Scherpbier HJ, de Koning LA, Heymans HS, Lange JM, Beijnen JH, Hoetelmans RM. van Heeswijk RP, et al. Among authors: hoetelmans rm. Ther Drug Monit. 2002 Aug;24(4):487-91. doi: 10.1097/00007691-200208000-00004. Ther Drug Monit. 2002. PMID: 12142631 Clinical Trial.
Dose-escalating study of the safety and pharmacokinetics of nelfinavir in HIV-exposed neonates.
Rongkavilit C, van Heeswijk RP, Limpongsanurak S, Thaithumyanon P, Boonrod C, Hassink EA, Srigritsanapol A, Chuenyam T, Ubolyam S, Hoetelmans RM, Ruxrungtham K, Lange JM, Cooper DA, Phanuphak P. Rongkavilit C, et al. Among authors: hoetelmans rm. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):455-63. doi: 10.1097/00042560-200204150-00005. J Acquir Immune Defic Syndr. 2002. PMID: 11981361 Clinical Trial.
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.
Baxter JD, Merigan TC, Wentworth DN, Neaton JD, Hoover ML, Hoetelmans RM, Piscitelli SC, Verbiest WH, Mayers DL; CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. Baxter JD, et al. Among authors: hoetelmans rm. AIDS. 2002 May 24;16(8):1131-8. doi: 10.1097/00002030-200205240-00006. AIDS. 2002. PMID: 12004271 Clinical Trial.
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
TMC125-C223 Writing Group, Nadler JP, Berger DS, Blick G, Cimoch PJ, Cohen CJ, Greenberg RN, Hicks CB, Hoetelmans RM, Iveson KJ, Jayaweera DS, Mills AM, Peeters MP, Ruane PJ, Shalit P, Schrader SR, Smith SM, Steinhart CR, Thompson M, Vingerhoets JH, Voorspoels E, Ward D, Woodfall B. TMC125-C223 Writing Group, et al. Among authors: hoetelmans rm. AIDS. 2007 Mar 30;21(6):F1-10. doi: 10.1097/QAD.0b013e32805e8776. AIDS. 2007. PMID: 17413684 Clinical Trial.
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
Cardiello PG, van Heeswijk RP, Hassink EA, Srasuebkul P, Mahanontharit A, Samor TM, Worarien W, Beijnen JH, Hoetelmans RM, Ruxrungtham K, Cooper DA, Lange JM, Phanuphak P. Cardiello PG, et al. Among authors: hoetelmans rm. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):464-70. doi: 10.1097/00042560-200204150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 11981362 Clinical Trial.
139 results